Aldeyra Therapeutics (ALDX +18.8%) hires Stephen Tuilpano as its new CFO effective June 23, 2014. He joins the company from accounting and management advisory firm Three Tulips where he was a consultant. Prior to that, he was CFO at Javelin Pharmaceuticals.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs